-+ 0.00%
-+ 0.00%
-+ 0.00%

BioNTech SE Enters Strategic Partnership with CureVac and GSK to Resolve Patent Litigation and Secure Non-Exclusive License for mRNA-Based COVID-19 and Influenza Products

Reuters·08/08/2025 06:14:18

Please log in to view news